Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-24

Clinical Trial Update: Additive Effect of Ezetimibe Upon Simvastatin During Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether adding ezetimibe to simvastatin provides additional benefit during myocardial infarction; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)
  • Zetia (ezetimibe)

Snippet

Sponsor: Brasilia Heart Study Group | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED